Proteros has relocated to a tailor-made facility in Martinsried

Martinsried, October 24th 2011. Proteros biostructures GmbH is further extending its business capacities by moving into a new building in Munich-Martinsried, one of the leading Biotech locations in Germany.

After a two-year planning period, Proteros has reached an important milestone in its development by centralizing all operations within a purpose-built facility. The 4,000 square-meter of laboratory and office space, worth a total of about 15 M €, has been optimally designed for Proteros’ specific requirements in protein production, X-Ray crystallography and kinetic analytics as well as medicinal chemistry and own synthesis group. The new facilities not only provide sufficient space for Proteros’ current over eighty employees, it also would enable the company to double its work-force within the next years. In addition, the company has achieved greater flexibility to broaden its technology platform, e.g. by operating a state-of-the art mammalian cell culture unit for protein production.

The design concept of the entire building incorporates proven innovative solutions from different industries and ideally supports Proteros’ industrialized processes. All employees will work in a most ergonomic lab environment that is expected to increase the creativity and efficiency in all work flows. Furthermore, the open spatial design facilitates communication amongst the different departments and creates an inspiring working environment for Proteros’ highly qualified scientific researchers. Major focus has also been laid on enabling the personnel to operate the laboratories in a sustainable and environmentally friendly manner.

About Proteros
Proteros is a privately held company, which provides services and proprietary technologies to support integrated drug discovery within life sciences. The company accelerates and improves protein structure analysis and structure-based drug discovery with its expertise, industrialized processes and unique technologies for crystallography and fragment-based lead generation. Proteros complements its clients’ internal capabilities with external expertise and access to flexible resources. Proteros currently provides services for more than 80 pharmaceutical and biotechnology clients in North America, Europe and Asia.

Contact:
Proteros biostructures GmbH
Dr. Thomas Waldmann
Director Business Development
Bunsenstr. 7a
82152 Martinsried
Germany
Phone: +49 (0)89 700 761-0
E-Mail: business@proteros.com
Website: www.proteros.com

This release was published on openPR.